Twitter | Search | |
Search Refresh
Jan Král Sep 18
Interesting case of rare squamous cell carcinoma, verrucous carcinoma, associated with tobacco and alcohol use.
Reply Retweet Like
Dr. M. Bernardo 10h
Towards individualized therapy for cell | Nature Reviews Clinical Oncology
Reply Retweet Like
SDEF Las Vegas Dermatology Seminar 7h
Laser treatment of basal cell continues to be refined
Reply Retweet Like
AJCP 21h
An unusual variant of atypical thymoma can be misdiagnosed as thymic or multilocular thymic . Learn more in .
Reply Retweet Like
Prostate Orgasm Sep 12
is also known as of the .
Reply Retweet Like
Hepatic Cell News Sep 12
Research published in | The SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular via restricting cellular activity.
Reply Retweet Like
Bichoy Gabra, R.Ph., Ph.D. Sep 17
On September 17, 2019, the granted accelerated approval to the combination of () plus () for the treatment of patients with advanced !
Reply Retweet Like
Stefano Cattaneo DVM Sep 18
Ki67 labelling index of neoplastic epithelial cells differentiates canine acanthomatous ameloblastoma from oral squamous cell
Reply Retweet Like
MedPage Oncology Sep 16
At , of , discussed her presentation on the current management approaches and associated prevention strategies for anal squamous cell .
Reply Retweet Like
FondationCancerFoie 15h
Reply Retweet Like
Markets Sep 13
Replying to @NewsoftheMarket
...– Oct 1 in Barcelona, Spain. The presentation will detail final safety & efficacy results from the Phase 2a portion of open-label Phase 1/2 clinical trial of mavorixafor in combination with axitinib in patients with advanced clear cell renal cell ()....
Reply Retweet Like
Dan Watson Sep 17
long FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
Reply Retweet Like
FondationCancerFoie Sep 15
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic in South Korea: No difference in terms of overall prognosis, including risk of : ->
Reply Retweet Like
Dr.Sanchayan Mandal Sep 15
Nivolumab for the of patients with metastatic non-clear cell renal cell (nccRCC): A single-institutional experience and literature meta-analysis
Reply Retweet Like
Anal Bioanal Chem Sep 17
A novel analysis method for identification based on horizontal relationship: identifying potential biomarkers from large-scale data by Peiyuan Yin et al
Reply Retweet Like
Medscape Oncology Sep 18
6 practice-changing hepatocellular treatment options.
Reply Retweet Like
SkinCancerFoundation Sep 12
Men, people 65 years and older, and those living in the southern U.S. are all at greater risk for cutaneous cell (CSCC). But the majority of them are unfamiliar with this widespread , according to our new survey with and .
Reply Retweet Like
Dermatology Advisor Sep 13
Loss of expression predicts poor overall survival in recurrent and disease of cutaneous cell . Click to read more.
Reply Retweet Like
Laboisse 8h
Pathological reporting of specimens: specimen sampling and evaluation of depth of .
Reply Retweet Like
ICAN Sep 18
Reply Retweet Like